Compile Data Set for Download or QSAR
Report error Found 92 Enz. Inhib. hit(s) with all data for entry = 1387
TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319796(US10174015, Compound 9)
Affinity DataIC50: 18nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319826(US10174015, Compound 39)
Affinity DataIC50: 27nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319818(US10174015, Compound 31)
Affinity DataIC50: 90nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319821(US10174015, Compound 34)
Affinity DataIC50: 130nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319793(US10174015, Compound 6)
Affinity DataIC50: 180nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319789(US10174015, Compound 2)
Affinity DataIC50: 210nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319795(US10174015, Compound 8)
Affinity DataIC50: 250nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319818(US10174015, Compound 31)
Affinity DataIC50: 260nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319792(US10174015, Compound 5)
Affinity DataIC50: 340nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319819(US10174015, Compound 32)
Affinity DataIC50: 350nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319794(US10174015, Compound 7)
Affinity DataIC50: 360nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319829(US10174015, Compound 42)
Affinity DataIC50: 370nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319823(US10174015, Compound 36)
Affinity DataIC50: 370nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319798(US10174015, Compound 11)
Affinity DataIC50: 380nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319820(US10174015, Compound 33)
Affinity DataIC50: 440nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319799(US10174015, Compound 12)
Affinity DataIC50: 450nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319828(US10174015, Compound 41)
Affinity DataIC50: 680nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319824(US10174015, Compound 37)
Affinity DataIC50: 850nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319814(US10174015, Compound 27)
Affinity DataIC50: 910nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319832(US10174015, Compound 45)
Affinity DataIC50: 920nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319825(US10174015, Compound 38)
Affinity DataIC50: 2.20E+3nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319801(US10174015, Compound 14)
Affinity DataIC50: 2.80E+3nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319808(US10174015, Compound 21)
Affinity DataIC50: 3.40E+3nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319812(US10174015, Compound 25)
Affinity DataIC50: 4.20E+3nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319797(US10174015, Compound 10)
Affinity DataIC50: 5.10E+3nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319827(US10174015, Compound 40)
Affinity DataIC50: 5.40E+3nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319833(US10174015, Compound 46)
Affinity DataIC50: 5.70E+3nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319790(US10174015, Compound 3)
Affinity DataIC50: 9.40E+3nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319802(US10174015, Compound 15)
Affinity DataIC50: 9.50E+3nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319800(US10174015, Compound 13)
Affinity DataIC50: 9.50E+3nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319809(US10174015, Compound 22)
Affinity DataIC50: 1.10E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319822(US10174015, Compound 35)
Affinity DataIC50: 1.12E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319810(US10174015, Compound 23)
Affinity DataIC50: 1.20E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319800(US10174015, Compound 13)
Affinity DataIC50: 1.50E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319827(US10174015, Compound 40)
Affinity DataIC50: 1.54E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319831(US10174015, Compound 44)
Affinity DataIC50: 1.58E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319791(US10174015, Compound 4)
Affinity DataIC50: 2.10E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319830(US10174015, Compound 43)
Affinity DataIC50: 2.35E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319805(US10174015, Compound 18)
Affinity DataIC50: 2.60E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319803(US10174015, Compound 16)
Affinity DataIC50: 2.67E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319791(US10174015, Compound 4)
Affinity DataIC50: 3.30E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319804(US10174015, Compound 17)
Affinity DataIC50: 3.42E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319788(US10174015, Compound 1)
Affinity DataIC50: 4.68E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319802(US10174015, Compound 15)
Affinity DataIC50: 5.50E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Xiamen University

US Patent
LigandPNGBDBM319790(US10174015, Compound 3)
Affinity DataIC50: 5.60E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319807(US10174015, Compound 20)
Affinity DataIC50: 6.53E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319806(US10174015, Compound 19)
Affinity DataIC50: 7.86E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319801(US10174015, Compound 14)
Affinity DataIC50: 7.92E+4nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319803(US10174015, Compound 16)
Affinity DataIC50: 1.00E+5nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

TargetN-acylethanolamine-hydrolyzing acid amidase(Human)
Xiamen University

US Patent
LigandPNGBDBM319804(US10174015, Compound 17)
Affinity DataIC50: 1.00E+5nMAssay Description:In the Experimental example, endocannabinoid hydrolases used were Fatty Acid Amide Hydrolase (FAAH) and N-acylethanolamide hydrolyzing acid amidase (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2019
Entry Details
US Patent

Displayed 1 to 50 (of 92 total ) | Next | Last >>
Jump to: